VCYTHealthcareMid-Cap

VERACYTE, INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for VERACYTE, INC. (VCYT), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are VCYT insiders buying or selling?

VERACYTE, INC. insiders reported 2 open-market buys ($1.1M) and 193 sells ($273.9M) across 195 Form 4 filings — a net selling position of $272.8M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 22, 2026)

Total Form 4 filings
195
SEC EDGAR
Insider filers
21
Insider buys (2)
$1.1M
Insider sells (193)
$273.9M

Insider sentiment

Net selling

Net insider flow of $272.8M in net selling.

Recent VCYT insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 22, 2026Karin EasthamDirectorSale3.7K$52.89$197.2K
Jun 5, 2026Annie McguireEVP, General CounselSale3.2K$49.76$158.0K
Jun 5, 2026Rebecca ChambersChief Financial OfficerSale3.6K$49.73$177.1K
Jun 5, 2026Marc StapleyChief Executive OfficerSale138.1K$50.12$6.9M
Jun 5, 2026John LeiteGlobal Chief Commercial OffSale14.0K$50.07$699.7K
May 27, 2026Jonathan WygantVP, Chief Accounting OfficerSale24.0K$45.40$1.1M
May 22, 2026Robert S EpsteinDirectorSale10.0K$44.01$440.1K
May 8, 2026Annie McguireSVP, General CounselSale10.2K$39.03$398.2K
Mar 6, 2026Rebecca ChambersChief Financial OfficerSale18.3K$36.14$662.9K
Mar 6, 2026Marc StapleyChief Executive OfficerSale45.5K$35.97$1.6M
Mar 6, 2026John LeiteChief Commercial Officer-CLIASale5.3K$35.19$185.1K
Mar 6, 2026Annie McguireSVP, General CounselSale6.7K$35.55$236.7K
Mar 4, 2026Phillip G. FebboChief Scientific & Med OfficerSale13.4K$36.16$485.4K
Dec 17, 2025Annie McguireSVP, General CounselSale10.7K$43.13$463.2K
Dec 8, 2025Karin EasthamDirectorSale20.0K$45.45$908.9K
Dec 5, 2025Annie McguireSVP, General CounselSale1.4K$47.30$67.3K
Dec 5, 2025Rebecca ChambersChief Financial OfficerSale13.3K$46.84$622.0K
Dec 5, 2025Marc StapleyChief Executive OfficerSale7.7K$47.09$361.1K
Dec 5, 2025John LeiteChief Commercial Officer-CLIASale1.3K$47.51$60.7K
Nov 26, 2025John LeiteChief Commercial Officer-CLIASale2.8K$50.00$140.4K
Nov 26, 2025Evan/ FA JonesDirectorSale1.1K$50.25$55.6K
Nov 21, 2025Jens HolsteinDirectorSale10.0K$42.36$423.6K
Nov 12, 2025Jonathan WygantVP, Chief Accounting OfficerSale10.9K$41.20$449.9K
Nov 7, 2025Annie McguireSVP, General CounselSale6.5K$40.00$258.6K
Nov 7, 2025Evan/ FA JonesDirectorSale43.2K$45.06$1.9M

Showing the 25 most recent of 195 Form 4 filings for VERACYTE, INC..

Most active VCYT insiders

  • Bonnie H Anderson41 filings
  • Giulia C Kennedy25 filings
  • Evan/ FA Jones22 filings
  • Karin Eastham18 filings
  • John Leite11 filings

Ask anything about VCYT insider activity

Use Trabud's AI agent to query VERACYTE, INC.'s Form 4 history in plain English — "Show me VCYT CEO purchases this year" or compare it against any other ticker.

Open the AI agent

VCYT insider trading FAQ

Are VERACYTE, INC. insiders buying or selling?

Across 195 SEC Form 4 filings, VERACYTE, INC. (VCYT) insiders reported 2 open-market purchases totaling $1.1M and 193 sales totaling $273.9M. That is a net selling position of $272.8M.

How many insiders trade VCYT stock?

21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for VERACYTE, INC.. The most recent filing was accepted on Jun 22, 2026.

Where does Trabud get VCYT insider trading data?

All VCYT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content